FDA approves Boehringer Ingelheim's Cyltezo for inflammatory ailments
The newly approved formulation will be offered as a pre-filled syringe or pre-filled autoinjector.
Source: yahoo.com
Stay updated with breaking news from Ochre Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The newly approved formulation will be offered as a pre-filled syringe or pre-filled autoinjector.
Check out this week’s medical marketing news, dealmaking and industry chatter.
Jack O’Meara’s Oxford based life-sciences company uses machine learning to develop RNA therapies for a range of chronic conditions
Oxford-based biotech company Ochre Bio is partnering with German-based Boehringer Ingelheim to develop treatments harnessing the liver’s natural capacity to regenerate.
University of Galway has announced the eight winners of the college’s 2024 Alumni Awards.